FDA warned Carolina Seafood that its ready-to-eat crab and shrimp dips had inadequate seafood hazard-control plans.
What happened
FDA inspected the seafood processing facility in McClellanville, SC, from April 29 to May 2, 2025, and found serious violations of the seafood HACCP (hazard-control) regulation, issuing a Form FDA 483 listing deviations. After the company submitted revised HACCP plans for ready-to-eat crab dip and shrimp dip in June 2025, FDA reviewed them and said concerns with the HACCP program remained.
What FDA found
The Crab Dip HACCP plan did not list metal inclusion and undeclared allergens as hazards reasonably likely to occur.
21 CFR 123.6(a) and (c)(1)The Crab Dip critical limits were not adequate to control Clostridium botulinum growth and toxin formation; FDA recommended keeping product at 40°F or below with ice or ice packs.
21 CFR 123.6(c)(3)The Crab Dip monitoring procedures did not adequately monitor actual time and temperature during unrefrigerated processing or visually examine ice.
21 CFR 123.6(c)(4)The Crab Dip corrective actions were not adequate, including not rejecting the lot or discontinuing the supplier when temperature control failed.
21 CFR 123.7(b)The Shrimp Dip critical limits were not adequate to control pathogen growth and toxin formation, including Listeria reduction and cumulative unrefrigerated time.
21 CFR 123.6(c)(3)The Shrimp Dip HACCP plan did not list metal inclusion, and its corrective actions at all critical control points did not include corrections for the cause of deviations.
21 CFR 123.6(a) and (c)(1); 21 CFR 123.7(b)
What FDA wants
FDA asks the company to reply in writing within 15 working days of receiving the letter describing the specific steps taken to address the violations, prevent recurrence, and provide related documents; if corrections cannot be completed, the company must explain the delay and timeframe.
Who should pay attention
- retailers and food service buyers of ready-to-eat seafood dips
- seafood processors making ready-to-eat dips
- brands relying on small or contract seafood manufacturers
This is a summary. Read the original letter on fda.gov.